Rabeprazole Sulfide

• CAT Number: R007333
• CAS Number: 117977-21-6
• Molecular Formula: C18H21N3O2S
• Molecular Weight: 343.44
• Purity: ≥95%
• Synonyms: 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole; ?2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]-methythio}-1H-benzimidazole; ?H 295/43; Rabeprazole Thioether; USP Rabeprazole Related Compound E
• Storage: RT
• IUPAC Name: 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole
• InChI: InChI=1S/C18H21N3O2S/c1-13-16(19-9-8-17(13)23-11-5-10-22-2)12-24-18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
• InChIKey: BSXAHDOWMOSVAP-UHFFFAOYSA-N
• SMILES: CC1=C(C=CN=C1CSC2=NC3=CC=CC=C3N2)OCCCOC

Rabeprazole Sulfide（Cat No.:R007333）, is the active metabolite of rabeprazole. Rabeprazole is a proton pump inhibitor used for the treatment of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. Rabeprazole thioether is formed when rabeprazole undergoes metabolic reactions in the body. It retains the pharmacological activity of rabeprazole, which involves reducing gastric acid secretion by inhibiting the proton pump enzyme. Rabeprazole thioether contributes to the therapeutic effects of rabeprazole in the treatment of acid-related disorders.